| Followers | 73 |
| Posts | 3281 |
| Boards Moderated | 0 |
| Alias Born | 03/16/2014 |
Tuesday, April 16, 2019 5:35:15 PM
Professor Ashkan ,,, but yep totally agree Top Line time line would be more than reasonable but , for whatever reason we are but an afterthought , a means to an end that now are irrelevant , David spending time on the phone to those that want to hear the script is good but he ain’t letting anything slip .
Flipper your time line earlier of AMRN 8000 patients vs NWBO 331 patients Top Line announcement is something I’m hanging onto in hope of Top Line in the coming weeks.
I believe they are ‘pedal to the metal’ because that’s what I want to hear ,
I believe David’s ‘ not rushing ‘ was a way of assuring us of no short cuts , but ‘pedal to the metal’ no less.
The fact for me is although I believe we will smash the endpoints and the long tail will make the world sit up and listen , the only thing that gets through to me is share price validation , hence .0005 green = happiness
.0005 red = misery .... My Macawber..
Thanks Flip , keep posting in earnest , it gives some of us the endorphins we crave .
Flipper your time line earlier of AMRN 8000 patients vs NWBO 331 patients Top Line announcement is something I’m hanging onto in hope of Top Line in the coming weeks.
I believe they are ‘pedal to the metal’ because that’s what I want to hear ,
I believe David’s ‘ not rushing ‘ was a way of assuring us of no short cuts , but ‘pedal to the metal’ no less.
The fact for me is although I believe we will smash the endpoints and the long tail will make the world sit up and listen , the only thing that gets through to me is share price validation , hence .0005 green = happiness
.0005 red = misery .... My Macawber..
Thanks Flip , keep posting in earnest , it gives some of us the endorphins we crave .
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
